The hot acquisition market in animal health seems to be continuing apace. There have been over 130 acquisitions noted in our newsletter through November of this year – with another 5 in this newsletter alone – and there are no doubt some we have missed.
Growth through acquisition seems to be a primary focus for many animal health companies large and small. In addition, private equity and other outside investors are paying impressive multiples to get into the animal health game. Most of these recently have been smaller, more strategic purchases. But now that the dust has settled from the Elanco/Bayer merger, is it possible there is another mega-merger in the offing? Only time will tell.
Last week we asked if you thought there will be a mega-merger in animal health in 2022 and a majority (56%) said no. A few respondents left responses with their merger candidates, but we’ll keep them under wraps – don’t want to start rumors!